AN2 Therapeutics (ANTX) Interest & Investment Income (2021 - 2026)
AN2 Therapeutics' (ANTX) quarterly Interest & Investment Income came in at $523000.0 in Q1 2026, down 41.1% year-on-year from $888000.0 in Q1 2025, and down 13.55% on a QoQ basis from $605000.0 in Q4 2025.
AN2 Therapeutics (ANTX) Interest & Investment Income (2021 - 2026) Analysis & Trends
AN2 Therapeutics (ANTX) has 5 years of Interest & Investment Income data on file, last reported at $523000.0 in Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 41.1% year-over-year to $523000.0 in Q1 2026; TTM through Mar 2026 was $2.6 million, a 45.06% decrease from a year earlier, with the FY2025 full-year figure at $2.9 million, down 46.32% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $523000.0, down from $605000.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for ANTX reached as high as $1.7 million in Q1 2024 and fell as low as $27000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $790307.7 across 4 years, with a median of $687000.0 in 2025.
- Across the five-year window, Interest & Investment Income jumped 2233.33% in 2022 and sank 47.82% in 2025, its largest moves.
- Year by year, Interest & Investment Income stood at $630000.0 in 2022, then soared by 70.79% to $1.1 million in 2024, then tumbled by 43.77% to $605000.0 in 2025, then fell by 13.55% to $523000.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $523000.0 in Q1 2026, $605000.0 in Q4 2025, and $687000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | AN2 Therapeutics | 168.26 Mn | 168.26 Mn | - | 523,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 523,000.00 |
| Dec 31, 2025 | 605,000.00 |
| Sep 30, 2025 | 687,000.00 |
| Jun 30, 2025 | 754,000.00 |
| Mar 31, 2025 | 888,000.00 |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | 1.27 Mn |
| Jun 30, 2024 | 1.45 Mn |
| Mar 31, 2024 | 1.68 Mn |
| Dec 31, 2022 | 630,000.00 |
| Sep 30, 2022 | 466,000.00 |
| Jun 30, 2022 | 228,000.00 |
| Mar 31, 2022 | 27,000.00 |
| Dec 31, 2021 | 27,000.00 |
| Sep 30, 2021 | 25,000.00 |
| Jun 30, 2021 | 15,000.00 |
| Mar 31, 2021 | 2,000.00 |